Literature DB >> 10721877

Delineating the longitudinal structure of depressive illness: beyond clinical subtypes and duration thresholds.

L L Judd1, H S Akiskal.   

Abstract

Through the use of polysomnographic, epidemiologic, and prospective clinical follow-up studies, the authors document that the course of major depressive disorder (MDD) is expressed by fluctuating symptoms in which depressive subtypes included in official diagnostic systems do not represent discrete disorders, but are stages along a dimensional continuum of symptomatic severity. Depressive symptoms at the major, minor, dysthymic or otherwise sub-threshold levels are all integral components of the longitudinal clinical structure of MDD with each symptom level representing a different phase of illness intensity, activity and severity. Detailed analyses indicate that patients are symptomatic 60 % of the time, much of it at the minor, dysthymic or subthreshold level. The symptomatic phases of illness activity are interspersed sporadically with inactive phases, when patients are asymptomatic. These findings are pertinent to both clinical cohorts and community-based epidemiologic samples. Each level of depressive symptom severity is associated with significant psychosocial impairment; such impairment increases progressively with each stepwise increment in symptom severity. When patients are asymptomatic their psychosocial functioning returns to good or very good levels. Residual subthreshold symptoms in the course of MDD are associated with high risk for early episode relapse and a significantly more chronic course of illness. Asymptomatic recovery from MDD is associated with significant delays in episode relapse and recurrence and a more benign course of illness. We submit that, as in the case of chronic medical conditions, the goal of treating unipolar depressive illness should optimally be to return the patient to as asymptomatic a level as is feasible by all available therapeutic means.

Entities:  

Mesh:

Year:  2000        PMID: 10721877     DOI: 10.1055/s-2000-7967

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  24 in total

1.  Neurobiological Underpinnings of the Estrogen - Mood Relationship.

Authors:  Whitney Wharton; Carey E Gleason; Sandra R M S Olson; Cynthia M Carlsson; Sanjay Asthana
Journal:  Curr Psychiatry Rev       Date:  2012-08-01

2.  Walking Ability and Its Relationship to Self-Rated Health in Later Life.

Authors:  Stewart Neufeld; Katerina Machacova; Jana Mossey; Mark Luborsky
Journal:  Clin Gerontol       Date:  2013-01       Impact factor: 2.619

3.  Cortical thinning in patients with late-life minor depression.

Authors:  Anand Kumar; Olusola Ajilore; Aifeng Zhang; Daniel Pham; Virginia Elderkin-Thompson
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

4.  The circadian basis of winter depression.

Authors:  Alfred J Lewy; Bryan J Lefler; Jonathan S Emens; Vance K Bauer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-28       Impact factor: 11.205

5.  "Energy is a Finite Resource": Designing Technology to Support Individuals across Fluctuating Symptoms of Depression.

Authors:  Rachel Kornfield; Renwen Zhang; Jennifer Nicholas; Stephen M Schueller; Scott A Cambo; David C Mohr; Madhu Reddy
Journal:  Proc SIGCHI Conf Hum Factor Comput Syst       Date:  2020-04

6.  Trajectory of Disability in Older Adults With Newly Diagnosed Diabetes: Role of Elevated Depressive Symptoms.

Authors:  Chao-Yi Wu; Lauren Terhorst; Jordan F Karp; Elizabeth R Skidmore; Juleen Rodakowski
Journal:  Diabetes Care       Date:  2018-08-02       Impact factor: 19.112

7.  The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys.

Authors:  Ronald C Kessler; Sergio Aguilar-Gaxiola; Jordi Alonso; Somnath Chatterji; Sing Lee; Johan Ormel; T Bedirhan Ustün; Philip S Wang
Journal:  Epidemiol Psichiatr Soc       Date:  2009 Jan-Mar

8.  Steps Following Attainment of Remission: Discontinuation of Antidepressant Therapy.

Authors:  Richard C. Shelton
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-08

9.  Changes in Depressive Symptoms and Mortality in Patients With Heart Failure: Effects of Cognitive-Affective and Somatic Symptoms.

Authors:  Boyoung Hwang; Debra K Moser; Michele M Pelter; Thomas S Nesbitt; Kathleen Dracup
Journal:  Psychosom Med       Date:  2015-09       Impact factor: 4.312

10.  Factor structure of the Hospital Anxiety and Depression Scale in Japanese psychiatric outpatient and student populations.

Authors:  Tomomi Matsudaira; Hiromi Igarashi; Hiroyoshi Kikuchi; Rikihachiro Kano; Hiroshi Mitoma; Kiyoshi Ohuchi; Toshinori Kitamura
Journal:  Health Qual Life Outcomes       Date:  2009-05-17       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.